Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2
- PMID: 34403832
- PMCID: PMC8364171
- DOI: 10.1016/j.meegid.2021.105038
Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genetic diversity has the potential to impact the virus transmissibility and the escape from natural infection- or vaccine-elicited neutralizing antibodies. Here, representative samples from circulating SARS-CoV-2 in Colombia between January and April 2021, were processed for genome sequencing and lineage determination following the nanopore amplicon ARTIC network protocol and PANGOLIN pipeline. This strategy allowed us to identify the emergence of the B.1.621 lineage, considered a variant of interest (VOI) with the accumulation of several substitutions affecting the Spike protein, including the amino acid changes I95I, Y144T, Y145S and the insertion 146 N in the N-terminal domain, R346K, E484K and N501Y in the Receptor binding Domain (RBD) and P681H in the S1/S2 cleavage site of the Spike protein. The rapid increase in frequency and fixation in a relatively short time in Magdalena, Atlantico, Bolivar, Bogotá D.C, and Santander that were near the theoretical herd immunity suggests an epidemiologic impact. Further studies will be required to assess the biological and epidemiologic roles of the substitution pattern found in the B.1.621 lineage.
Keywords: Emergence; Evolution; SARS-CoV-2; Variant of interest (VOI).
Copyright © 2021 Elsevier B.V. All rights reserved.
Figures
References
-
- Bal A., Destras G., Gaymard A., Stefic K., Marlet J., Eymieux S., et al. Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69–V70, France, August to December 2020. Eurosurveillance. 2021 Jan 21;26(3):2100008. doi: 10.2807/1560-7917.ES.2021.26.3.2100008. [Internet]. [cited 2021 May 4]. Available from: - DOI - PMC - PubMed
-
- CDC SARS-CoV-2 variants of concern as of 4 May 2021 [Internet] 2021. https://www.ecdc.europa.eu/en/covid-19/variants-concern [cited 2021 May 4]. Available from:
-
- Davies N.G., Abbott S., Barnard R.C., Jarvis C.I., Kucharski A.J., Munday J.D., et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science (80-) 2021 Apr 9;372(6538) https://science.sciencemag.org/content/372/6538/eabg3055 [Internet]. [cited 2021 Apr 30]. eabg3055. Available from: - PMC - PubMed
-
- Garcia-Beltran W.F., Lam E.C., St. Denis K., Nitido A.D., Garcia Z.H., Hauser B.M., et al. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell. 2021 Apr 29;184(9) doi: 10.1016/j.cell.2021.03.013. [Internet]. 2372-2383.e9. Available from:. [cited 2021 May 1] - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
